Breast Cancer Trial, Recruiting NCT06777420 Sponsor: Region Örebro County Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06777420
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have breast cancer that can be treated with surgery, and where doctors consider them suitable for systemic treatment given before surgery (called neoadjuvant therapy), based on current medical guidelines.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose breast cancer has spread locally to a point where pre-surgery treatment is considered medically required rather than one option among several.
  • People who have cognitive difficulties that their treating doctor has assessed as making participation in the trial not possible.
  • People who are not able to speak or read either Swedish or English.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Antonis Valachis, MD, PhD, Department of Oncology, Örebro University Hospital, Sweden

Phone: +46 0196021792

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Region Örebro County
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
1 January 2027

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Concordance rate between patient and oncologist

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov